Skip to main content
. 2003 Sep;69(9):5343–5353. doi: 10.1128/AEM.69.9.5343-5353.2003

TABLE 2.

Bioassay results for four species of mosquitoes

Toxin LC50 (ng/ml)a
A. quadrimaculatus A. aegypti C. quinquefasciatus C. pipiens
Cry4Aa ND 600 (1,300-2,000)b 980 (680-1,490)c 400 (300-500)b
Cry4Ba 25 (18-32) 61 (28-175) >80,000d >20,000g
4BwtGAV 745 (607-962) 174 (117-280) >20,000f ND
4BRA 21 (15-29) 21 (5-51) >80,000e >20,000d
4BL1QTT >20,000d >20,000c >20,000d ND
4BL2NDY >20,000d >20,000d >20,000d ND
4BL3PAT 44 (40-50) 53 (19-91) 365 (267-529) 95 (69-130)
4BL3AAT 16 (8-23) 68 (19-140) 1,035 (485-8,972) 229 (142-512)
4BL3GAT 88 (64-119) 64 (39-94) 122 (75-189) 180 (117-317)
4BL3GAV 52 (32-74) 44 (20-68) 114 (83-150) 70 (34-129)
4BL3PAA 197 (136-328) 144 (75-277) 4,000 (1,948-14,838) 481 (44-988)
4BL3AAA 23 (17-30) 82 (50-126) >20,000e 630 (306-11,328)
a

Two-day-old larvae of A. aegypti, C. quinquefasciatus, and C. pipiens and 3-day-old larvae of A. quadrimaculatus were used for bioassays. Mortality was recorded after 24 h of exposure to a serial dilution of the toxins. The 95% confidence limits are indicated in parentheses. Bioassays for the Cry4B constructs used purified inclusion crystal protein produced in E. coli. ND, not determined. LC50, 50% lethal, concentration.

b

Data from reference 14.

c

Data from reference 2.

d

8% mortality was observed at this dose.

e

No mortality was observed.

f

17% mortality was observed at this dose.

g

8% mortality was observed at this dose.